Yousef Bader, MD
Clinical Cardiac Electrophysiology · Bay City, MINPI 1205063898
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $57,240 of the $76,485 with a category attached, or 74.8%. Edwards Lifesciences accounts for 93.9% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $41,259 and has fallen 98.6% since, to $582 in 2025.
Across 271 payments — averaging $282.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$72K
- Abbott$2K
- Novartis$611
- Shockwave Medical, Inc$417
- Amgen$303
- Abiomed$207
- plus $2K from 20 others
Across 1 payment — averaging $1028.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
What the payments were for
- Consulting fees$57,24075%
- Speaking & faculty fees$8,48011%
- Travel & lodging$4,6036%
- Food & beverage$6,1458%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 110 | $71,812 |
| Abbott | 22 | $1,592 |
| Novartis | 48 | $611 |
| Shockwave Medical, Inc | 10 | $417 |
| Amgen | 11 | $303 |
| Abiomed | 3 | $207 |
| AstraZeneca | 8 | $187 |
| Ardelyx, Inc. | 9 | $181 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $135 |
| Boston Scientific | 4 | $133 |
| Vifor Pharma, Inc. | 6 | $128 |
| Lexicon Pharmaceuticals, Inc. | 1 | $125 |
| Medtronic(2 entities) | 4 | $113 |
| Johnson & Johnson | 2 | $109 |
| Calliditas Therapeutics US Inc. | 3 | $79 |
| E.r. Squibb & Sons, L.L.C. | 4 | $66 |
| Cardiovascular Systems Inc. | 6 | $56 |
| EKOS Corporation | 1 | $54 |
| Cardiva Medical, Inc. | 2 | $45 |
| Actelion Pharmaceuticals US, Inc. | 2 | $37 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
| OPKO Pharmaceuticals, LLC | 1 | $17 |
| Pfizer | 1 | $17 |
| GSK | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$69,699
- Cardiac Mapping System$881
- SAPIEN 3 Ultra RESILIA$295
- Inpefa$125
- XIENCE SIERRA$125
- Repatha$115
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$114
- MitraClip System$111
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$106
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$103
How this compares
$76,485 in reported general payments places this provider in the 85th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
See all clinical cardiac electrophysiology providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 289 | $352,690 |
| XareltoRivaroxaban | 50 | $67,395 |
| EntrestoSacubitril/Valsartan | 50 | $67,234 |
| Repatha SureclickEvolocumab | 31 | $40,421 |
| JardianceEmpagliflozin | 11 | $12,631 |
| ClopidogrelClopidogrel Bisulfate | 181 | $3,376 |
| Metoprolol Succinate | 163 | $3,159 |
| Bumetanide | 18 | $2,096 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 94 | $1,740 |
| Nifedipine ErNifedipine | 42 | $1,583 |
| Atorvastatin Calcium | 117 | $1,456 |
| Ezetimibe | 39 | $1,262 |
| Rosuvastatin Calcium | 46 | $1,179 |
| Metoprolol Tartrate | 148 | $1,017 |
| Potassium Chloride | 35 | $958 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $352,690289 claims |
| Johnson & JohnsonXarelto | $109 | $67,39550 claims |
| NovartisEntresto | $611 | $67,23450 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
Other clinical cardiac electrophysiology in Bay City
- Randy LiebermanDetroit$1.2M
- Asim YunusSaginaw$236K
- Jackson LiangAnn Arbor$229K
- Ryan CunnaneAnn Arbor$218K
- Dipak ShahSouthfield$194K
- Rakesh LatchamsettyBrighton$165K
- Ilana KutinskyTroy$138K
- Nishaki MehtaRoyal Oak$133K
- Andre GauriGrand Rapids$126K
- Daniel AlyeshAnn Arbor$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.